Christianne L Roumie1, Alan J Zillich2, Dawn M Bravata2, Heather A Jaynes2, Laura J Myers2, Joseph Yoder2, Eric M Cheng2. 1. From the Veterans Health Administration, Tennessee Valley Healthcare System Geriatric Research Education Clinical Center, Nashville (C.L.R.); Department of Medicine, Vanderbilt University, Nashville, TN (C.L.R.); Center for Health Information and Communication, Health Service and Research Development, Roudebush Veterans Affairs Medical Center, Indianapolis, IN (A.J.Z., D.M.B., H.A.J., L.J.M., J.Y.); Department of Pharmacy Practice, Purdue University, West Lafayette, IN (A.J.Z.); Department of Internal Medicine and Geriatrics, Indiana University School of Medicine, Indianapolis (D.M.B., L.J.M.); Health Services Research and Development Stroke Quality Enhancement Research Initiative (D.M.B.); Health Services Research Section, Regenstrief Institute, Indianapolis, IN (D.M.B., L.J.M.); Department of Neurology, Greater Los Angeles Veterans Affairs Medical Center, CA (E.M.C.); and Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles (E.M.C.). Christianne.roumie@vanderbilt.edu. 2. From the Veterans Health Administration, Tennessee Valley Healthcare System Geriatric Research Education Clinical Center, Nashville (C.L.R.); Department of Medicine, Vanderbilt University, Nashville, TN (C.L.R.); Center for Health Information and Communication, Health Service and Research Development, Roudebush Veterans Affairs Medical Center, Indianapolis, IN (A.J.Z., D.M.B., H.A.J., L.J.M., J.Y.); Department of Pharmacy Practice, Purdue University, West Lafayette, IN (A.J.Z.); Department of Internal Medicine and Geriatrics, Indiana University School of Medicine, Indianapolis (D.M.B., L.J.M.); Health Services Research and Development Stroke Quality Enhancement Research Initiative (D.M.B.); Health Services Research Section, Regenstrief Institute, Indianapolis, IN (D.M.B., L.J.M.); Department of Neurology, Greater Los Angeles Veterans Affairs Medical Center, CA (E.M.C.); and Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles (E.M.C.).
Abstract
BACKGROUND AND PURPOSE: We examined blood pressure 1 year after stroke discharge and its association with treatment intensification. METHODS: We examined the systolic blood pressure (SBP) stratified by discharge SBP (≤140, 141-160, or >160 mm Hg) among a national cohort of Veterans discharged after acute ischemic stroke. Hypertension treatment opportunities were defined as outpatient SBP >160 mm Hg or repeated SBPs >140 mm Hg. Treatment intensification was defined as the proportion of treatment opportunities with antihypertensive changes (range, 0%-100%, where 100% indicates that each elevated SBP always resulted in medication change). RESULTS: Among 3153 patients with ischemic stroke, 38% had ≥1 elevated outpatient SBP eligible for treatment intensification in the 1 year after stroke. Thirty percent of patients had a discharge SBP ≤140 mm Hg, and an average 1.93 treatment opportunities and treatment intensification occurred in 58% of eligible visits. Forty-seven percent of patients discharged with SBP 141 to160 mm Hg had an average of 2.1 opportunities for intensification and treatment intensification occurred in 60% of visits. Sixty-three percent of the patients discharged with an SBP >160 mm Hg had an average of 2.4 intensification opportunities, and treatment intensification occurred in 65% of visits. CONCLUSIONS: Patients with discharge SBP >160 mm Hg had numerous opportunities to improve hypertension control. Secondary stroke prevention efforts should focus on initiation and review of antihypertensives before acute stroke discharge; management of antihypertensives and titration; and patient medication adherence counseling.
BACKGROUND AND PURPOSE: We examined blood pressure 1 year after stroke discharge and its association with treatment intensification. METHODS: We examined the systolic blood pressure (SBP) stratified by discharge SBP (≤140, 141-160, or >160 mm Hg) among a national cohort of Veterans discharged after acute ischemic stroke. Hypertension treatment opportunities were defined as outpatient SBP >160 mm Hg or repeated SBPs >140 mm Hg. Treatment intensification was defined as the proportion of treatment opportunities with antihypertensive changes (range, 0%-100%, where 100% indicates that each elevated SBP always resulted in medication change). RESULTS: Among 3153 patients with ischemic stroke, 38% had ≥1 elevated outpatient SBP eligible for treatment intensification in the 1 year after stroke. Thirty percent of patients had a discharge SBP ≤140 mm Hg, and an average 1.93 treatment opportunities and treatment intensification occurred in 58% of eligible visits. Forty-seven percent of patients discharged with SBP 141 to160 mm Hg had an average of 2.1 opportunities for intensification and treatment intensification occurred in 60% of visits. Sixty-three percent of the patients discharged with an SBP >160 mm Hg had an average of 2.4 intensification opportunities, and treatment intensification occurred in 65% of visits. CONCLUSIONS:Patients with discharge SBP >160 mm Hg had numerous opportunities to improve hypertension control. Secondary stroke prevention efforts should focus on initiation and review of antihypertensives before acute stroke discharge; management of antihypertensives and titration; and patient medication adherence counseling.
Authors: R C Kaplan; D L Tirschwell; W T Longstreth; T A Manolio; S R Heckbert; D Lefkowitz; A El-Saed; B M Psaty Journal: Neurology Date: 2005-09-27 Impact factor: 9.910
Authors: Fred Stephen Sarfo; Gloria Kyem; Bruce Ovbiagele; John Akassi; Osei Sarfo-Kantanka; Martin Agyei; Elizabeth Badu; Nathaniel Adusei Mensah Journal: J Stroke Cerebrovasc Dis Date: 2016-09-14 Impact factor: 2.136
Authors: Santosh B Murthy; Ivan Diaz; Xian Wu; Alexander E Merkler; Costantino Iadecola; Monika M Safford; Kevin N Sheth; Babak B Navi; Hooman Kamel Journal: Stroke Date: 2019-11-27 Impact factor: 7.914
Authors: Anna-Lotta Irewall; Joachim Ögren; Lisa Bergström; Katarina Laurell; Lars Söderström; Thomas Mooe Journal: PLoS One Date: 2015-10-16 Impact factor: 3.240